Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy:risk factors and survivalOACSCDCSTPCD
Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy:risk factors and survival
Kai-Lin Chen;De-Hui Zou;Li-Yang Hu;Michael Lucas Wirian;Qing-Qing Cai;Jie Chen;Hui-Lan Rao;Ying Guo;Hui-Qiang Huang;Liang Zhang;Jian-Yong Shao;Tong-Yu Lin;Wen-Qi Jiang
Sun Yat-sen University Cancer Center State Key Laboratory of 0ncology in South China Col aborative Innovation Center of Cancer Medicine, Guangzhou 510060, Guangdong, P. R. ChinaLymphoma and Myeloma Center, Institute of Hematology and Blood Diseases Hospital, Tianjin, P. R. ChinaSun Yat-sen University Cancer Center State Key Laboratory of 0ncology in South China Col aborative Innovation Center of Cancer Medicine, Guangzhou 510060, Guangdong, P. R. ChinaSun Yat-sen University Cancer Center State Key Laboratory of 0ncology in South China Col aborative Innovation Center of Cancer Medicine, Guangzhou 510060, Guangdong, P. R. ChinaSun Yat-sen University Cancer Center State Key Laboratory of 0ncology in South China Col aborative Innovation Center of Cancer Medicine, Guangzhou 510060, Guangdong, P. R. ChinaGuangdong Province Key Laboratory of Ar hythmia and Electrophysiology, Radiotherapy Department, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou 510120, Guangdong, P. R. ChinaSun Yat-sen University Cancer Center State Key Laboratory of 0ncology in South China Col aborative Innovation Center of Cancer Medicine, Guangzhou 510060, Guangdong, P. R. ChinaSun Yat-sen University Cancer Center State Key Laboratory of 0ncology in South China Col aborative Innovation Center of Cancer Medicine, Guangzhou 510060, Guangdong, P. R. ChinaSun Yat-sen University Cancer Center State Key Laboratory of 0ncology in South China Col aborative Innovation Center of Cancer Medicine, Guangzhou 510060, Guangdong, P. R. ChinaDepartment of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USASun Yat-sen University Cancer Center State Key Laboratory of 0ncology in South China Col aborative Innovation Center of Cancer Medicine, Guangzhou 510060, Guangdong, P. R. ChinaSun Yat-sen University Cancer Center State Key Laboratory of 0ncology in South China Col aborative Innovation Center of Cancer Medicine, Guangzhou 510060, Guangdong, P. R. ChinaSun Yat-sen University Cancer Center State Key Laboratory of 0ncology in South China Col aborative Innovation Center of Cancer Medicine, Guangzhou 510060, Guangdong, P. R. China
Diffuse large B-cell lymphomaHepatitisHepatitis B virus reactivationResolved hepatitis B
Diffuse large B-cell lymphomaHepatitisHepatitis B virus reactivationResolved hepatitis B
《癌症（英文版）》 2015 (5)
miR-374b靶向AKT诱导T细胞淋巴瘤细胞凋亡的研究
225-236,12
This work was supported by the National Natural Science Foundation of China (No.81372883, No.81001052), the Science and Technology Planning Project of Guangdong Province, China (No.2011B031800222), the Young Talents Project of Sun Yat-sen University Cancer Center (to QC), the Young Talents Project of Sun Yat-sen University (to QC), the Natural Science Foundation of Guangdong Province, China (No.8151008901000043), and the Sister Institution Network Fund of MD Anderson Cancer Center (to HR). This research was also partly supported by the NIH through MD Anderson’s Cancer Center Support Grant (No. CA016672)
评论